COVID-19 : Overview of Rheumatology Fellows
Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved..
SARS-CoV-2 infection has spread worldwide since it originated in December 2019, in Wuhan, China. The pandemic has largely demonstrated the resilience of the world's health systems and is the greatest health emergency since World War II. There is no single therapeutic approach to the treatment of COVID-19 and the associated immune disorder. The lack of randomised clinical trials (RCTs) has led different countries to tackle the disease based on case series, or from results of observational studies with off-label drugs. We as rheumatologists in general, and specifically rheumatology fellows, have been on the front line of the pandemic, modifying our activities and altering our training itinerary. We have attended patients, we have learned about the management of the disease and from our previous experience with drugs for arthritis and giant cell arteritis, we have used these drugs to treat COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2020 |
|---|---|
| Enthalten in: |
Reumatologia clinica - (2020) vom: 11. Juni |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
COVID-19: La visión del residente de reumatología |
|---|
| Beteiligte Personen: |
Garcia-Guillén, Andrea [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biológicos |
|---|
| Anmerkungen: |
Date Revised 27.02.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.reuma.2020.05.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311436528 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311436528 | ||
| 003 | DE-627 | ||
| 005 | 20240229163009.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.reuma.2020.05.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1308.xml |
| 035 | |a (DE-627)NLM311436528 | ||
| 035 | |a (NLM)32565030 | ||
| 035 | |a (PII)S1699-258X(20)30134-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Garcia-Guillén, Andrea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 |b Overview of Rheumatology Fellows |
| 246 | 3 | 3 | |a COVID-19: La visión del residente de reumatología |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved. | ||
| 520 | |a SARS-CoV-2 infection has spread worldwide since it originated in December 2019, in Wuhan, China. The pandemic has largely demonstrated the resilience of the world's health systems and is the greatest health emergency since World War II. There is no single therapeutic approach to the treatment of COVID-19 and the associated immune disorder. The lack of randomised clinical trials (RCTs) has led different countries to tackle the disease based on case series, or from results of observational studies with off-label drugs. We as rheumatologists in general, and specifically rheumatology fellows, have been on the front line of the pandemic, modifying our activities and altering our training itinerary. We have attended patients, we have learned about the management of the disease and from our previous experience with drugs for arthritis and giant cell arteritis, we have used these drugs to treat COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Biological agents | |
| 650 | 4 | |a Biológicos | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Pandemia | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a Resident | |
| 650 | 4 | |a Residente | |
| 650 | 4 | |a Reumatólogos | |
| 650 | 4 | |a Rheumatologists | |
| 700 | 1 | |a Jeria, Sicylle |e verfasserin |4 aut | |
| 700 | 1 | |a Lobo-Prat, David |e verfasserin |4 aut | |
| 700 | 1 | |a Sainz, Luís |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Reumatologia clinica |d 2011 |g (2020) vom: 11. Juni |w (DE-627)NLM213092891 |x 2173-5743 |7 nnns |
| 773 | 1 | 8 | |g year:2020 |g day:11 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.reuma.2020.05.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2020 |b 11 |c 06 | ||